Screening system | Nanobodies from a llama named Wally | Clean air
NAVIGATING THE RECOVERY
Flyover Country fights the pandemic
A special report from: 
FLYOVER U
University of Illinois "Shield" COVID-19 screening system 
Image by Fred Zwicky for University of Illinois
Colleges and universities have had to make major adjustments to keep their schools open during the pandemic. Measures include testing, temperature checks, contact tracing, and more. But the University of Illinois at Urbana-Champaign may have outdone them all. A remarkable system called “Shield” is screening tens of thousands of people every day, and a homegrown data system and app are keeping the classrooms open.
Undergrads are tested two to three times per week. If the person tests positive, they must self-isolate. The university is optimistic that the system will work to keep COVID at bay but hopes easier testing will be widely available for everybody soon. Another factor is the high price tag. The school spent about $7 million to get the system up and running and spends another $3 to $5 million every month.
INNOVATION SPOTLIGHT With Hive Networks
Something to teach, something to learn 
Dr. Kedar Mate, President and Chief Executive of IHI
IHI (Institute for Healthcare Improvement) is a non-profit organization headquartered in Boston that works to improve health and healthcare organizations in over 30 countries. Dr. Kedar Mate, President and Chief Executive of IHI, talks about the institute’s mission and how Cincy’s Hive Networks is playing a pivotal role.
You’re very involved with LHNs (Learning Health Networks). Can you explain the concept?
Dr. Mate: IHI works from the axiom All Teach, All Learn. Everyone has something to teach and everyone has something to learn. That thesis was incorporated into LHNs for improving specific health outcomes for patients. LHNs are a marriage of the research community, provider community, and the patient community. All are teaching and learning from each other to improve health outcomes. That 3-part network has been so incredibly critical to the pace and the scale of the work.
What does Hive Networks contribute to the mission?
Dr. Mate: The LHN was essentially an academic model created by Cincinnati Children’s Hospital with help from IHI. We needed a way to push it out to a broader audience. We wanted to make it so that anyone who wanted to start a network like this could. That’s what Hive Networks has pioneered.
Hive has created the data architecture and the community architecture that enables any clinical community to come together more rapidly and to take better care of patients. Hive took us into the realm of “anyone who wants to start a network can have the ability to do so.”
Can you give us an example of how LHNs are succeeding?
Dr. Mate: LHNs in general have made amazing advancements. One example is the LHN for in inflammatory bowel disease (IBD). That network now includes 30,000 patients. That means that almost all kids with IBD are in this network now. The aggregate remission rate for kids with IBD went from an average of 50% to 80% in the last decade. Substantial outcomes for these kids: It means they can go to school, they can go to the prom. Things that weren’t possible before remission.
We also have a network for children born with a rare heart syndrome in which the left side of their heart is not working properly. It requires two surgeries to fix before the child is one years old. What was happening is that some children were dying between the surgeries. What was discovered through the LHN is that there were medications that could be administered between the surgeries that could increase the survival rate by 40%.
To learn more about the Learning Health Network model and Hive Networks, visit www.hivenetworks.com. To learn more about the Institute of Healthcare Improvement visit www.ihi.org. Share this story!
COVID-19, Pitt, and a llama named Wally Scientists at the University of Pittsburgh have discovered a potentially revolutionary treatment for COVID-19. They used mass spectrometry to pull out tiny antibodies—called nanobodies—from a COVID-immunized llama named Wally. Wally’s nanobodies work like the convalescent plasma from humans that doctors have been using for awhile now. But the nanobodies have several advantages over normal antibodies: They are a fraction of the size, are orders of magnitude more powerful, and can be shipped at room temperature.
Are our eyes safe from COVID? A study by researchers at Washington University School of Medicine suggests that our corneas can resist infection from the virus that causes COVID-19. If that belongs in the category of things you didn’t know you needed to worry about, it looks like you needn’t worry. While the study isn’t conclusive, none of the corneas from mice or human donors became infected. That’s significant because other viruses like Zika and herpes simplex can infect the cornea and spread to other parts of the body.
UC cardiologist develops COVID app for Black communities A cardiologist at the University of Cincinnati is developing an app with COVID-19 and other health-related information specifically for Black communities. Donald Lynch, assistant professor of cardiovascular health and disease at UC, wants to empower Black people to help fight the disease that is disproportionally affecting their communities.
PANDEMIC INNOVATION
Cleaning COVID-19 aerosol out of indoor air Dynamics Inc., a Pittsburgh company, has invented a product that deactivates aerosolized COVID-19 virus from indoor air. The product, dubbed Nanowave Air, looks like a rocket on top of a tripod. It deploys four motors to pull in air at high speed and uses high-intensity ultraviolet light to destroy the virus. Multiple lab tests, including the NIAID Biodefense Laboratory Network, confirmed the device deactivated 99% of coronavirus.
REACH OUT Share stories, offer suggestions, or comment!
|
